{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:47:48Z","timestamp":1794746868107,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T00:00:00Z","timestamp":1372118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/nrneurol.2013.118","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T10:19:19Z","timestamp":1372155559000},"page":"455-461","source":"Crossref","is-referenced-by-count":340,"title":["The spectrum of MOG autoantibody-associated demyelinating diseases"],"prefix":"10.1038","volume":"9","author":[{"given":"Markus","family":"Reindl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Di Pauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rost\u00e1sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,25]]},"reference":[{"key":"BFnrneurol2013118_CR1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502\u20131517 (2008).","journal-title":"Lancet"},{"key":"BFnrneurol2013118_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-pathol-011811-132443","volume":"7","author":"BF Popescu","year":"2012","unstructured":"Popescu, B. F. & Lucchinetti, C. F. Pathology of demyelinating diseases. Annu. Rev. Pathol. 7, 185\u2013217 (2012).","journal-title":"Annu. Rev. Pathol."},{"key":"BFnrneurol2013118_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.autrev.2011.05.014","volume":"11","author":"K Conrad","year":"2012","unstructured":"Conrad, K., Roggenbuck, D., Reinhold, D. & Sack, U. Autoantibody diagnostics in clinical practice. Autoimmun. Rev. 11, 207\u2013211 (2012).","journal-title":"Autoimmun. Rev."},{"key":"BFnrneurol2013118_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2006.06.028","volume":"180","author":"M Reindl","year":"2006","unstructured":"Reindl, M., Khalil, M. & Berger, T. Antibodies as biological markers for pathophysiological processes in MS. J. Neuroimmunol. 180, 50\u201362 (2006).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol2013118_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbadis.2010.07.020","volume":"1812","author":"AH Cross","year":"2011","unstructured":"Cross, A. H. & Waubant, E. MS and the B cell controversy. Biochim. Biophys. Acta 1812, 231\u2013238 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneurol2013118_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrneurol.2012.203","volume":"8","author":"M Krumbholz","year":"2012","unstructured":"Krumbholz, M., Derfuss, T., Hohlfeld, R. & Meinl, E. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat. Rev. Neurol. 8, 613\u2013623 (2012).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol2013118_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1756285611433772","volume":"5","author":"MC Mayer","year":"2012","unstructured":"Mayer, M. C. & Meinl, E. Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more. Ther. Adv. Neurol. Disord. 5, 147\u2013159 (2012).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"BFnrneurol2013118_CR8","doi-asserted-by":"publisher","first-page":"7990","DOI":"10.1073\/pnas.90.17.7990","volume":"90","author":"D Pham-Dinh","year":"1993","unstructured":"Pham-Dinh, D. et al. Myelin\/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl Acad. Sci. USA 90, 7990\u20137994 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2013118_CR9","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1046\/j.1471-4159.1994.63062353.x","volume":"63","author":"D Pham-Dinh","year":"1994","unstructured":"Pham-Dinh, D. et al. Characterization and expression of the cDNA coding for the human myelin\/oligodendrocyte glycoprotein. J. Neurochem. 63, 2353\u20132356 (1994).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2013118_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1471-4159.1989.tb10930.x","volume":"52","author":"C Brunner","year":"1989","unstructured":"Brunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J. M. & Linington, C. Differential ultrastructural localization of myelin basic protein, myelin\/oligodendroglial glycoprotein, and 2\u2032,3\u2032-cyclic nucleotide 3\u2032-phosphodiesterase in the CNS of adult rats. J. Neurochem. 52, 296\u2013304 (1989).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2013118_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1471-4159.1999.0720001.x","volume":"72","author":"TG Johns","year":"1999","unstructured":"Johns, T. G. & Bernard, C. C. The structure and function of myelin oligodendrocyte glycoprotein. J. Neurochem. 72, 1\u20139 (1999).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2013118_CR12","first-page":"423","volume":"66","author":"R Lebar","year":"1986","unstructured":"Lebar, R., Lubetzki, C., Vincent, C., Lombrail, P. & Boutry, J. M. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin. Exp. Immunol. 66, 423\u2013434 (1986).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneurol2013118_CR13","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.4049\/jimmunol.139.12.4016","volume":"139","author":"HJ Schluesener","year":"1987","unstructured":"Schluesener, H. J., Sobel, R. A., Linington, C. & Weiner, H. L. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139, 4016\u20134021 (1987).","journal-title":"J. Immunol."},{"key":"BFnrneurol2013118_CR14","first-page":"443","volume":"130","author":"C Linington","year":"1988","unstructured":"Linington, C., Bradl, M., Lassmann, H., Brunner, C. & Vass, K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein. Am. J. Pathol. 130, 443\u2013454 (1988).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol2013118_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/glia.1111","volume":"36","author":"A Iglesias","year":"2001","unstructured":"Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A. & Linington, C. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36, 220\u2013234 (2001).","journal-title":"Glia"},{"key":"BFnrneurol2013118_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1084\/jem.20021603","volume":"197","author":"E Bettelli","year":"2003","unstructured":"Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073\u20131081 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrneurol2013118_CR17","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1172\/JCI28330","volume":"116","author":"G Krishnamoorthy","year":"2006","unstructured":"Krishnamoorthy, G., Lassmann, H., Wekerle, H. & Holz, A. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell\/B cell cooperation. J. Clin. Invest. 116, 2385\u20132392 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2013118_CR18","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1172\/JCI28334","volume":"116","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E., Baeten. D., J\u00e4ger. A., Sobel, R. A., Kuchroo. V. K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 116, 2393\u20132402 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2013118_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer, K. et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479, 538\u2013541 (2011).","journal-title":"Nature"},{"key":"BFnrneurol2013118_CR20","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/eji.200425050","volume":"34","author":"HC von Budingen","year":"2004","unstructured":"von Budingen, H. C. et al. Frontline: epitope recognition on the myelin\/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur. J. Immunol. 34, 2072\u20132083 (2004).","journal-title":"Eur. J. Immunol."},{"key":"BFnrneurol2013118_CR21","doi-asserted-by":"publisher","first-page":"13992","DOI":"10.1073\/pnas.0504979102","volume":"102","author":"CB Marta","year":"2005","unstructured":"Marta, C. B., Oliver, A. R., Sweet, R. A., Pfeiffer, S. E. & Ruddle, N. H. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc. Natl Acad. Sci. USA 102, 13992\u201313997 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2013118_CR22","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1073\/pnas.0510672103","volume":"103","author":"PH Lalive","year":"2006","unstructured":"Lalive, P. H. et al. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc. Natl Acad. Sci. USA 103, 2280\u20132285 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2013118_CR23","doi-asserted-by":"publisher","first-page":"19057","DOI":"10.1073\/pnas.0607242103","volume":"103","author":"D Zhou","year":"2006","unstructured":"Zhou, D. et al. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl Acad. Sci. USA 103, 19057\u201319062 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2013118_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm1488","volume":"13","author":"KC O'Connor","year":"2007","unstructured":"O'Connor, K. C. et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat. Med. 13, 211\u2013217 (2007).","journal-title":"Nat. Med."},{"key":"BFnrneurol2013118_CR25","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.4049\/jimmunol.0801888","volume":"183","author":"KA McLaughlin","year":"2009","unstructured":"McLaughlin, K. A. et al. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J. Immunol. 183, 4067\u20134076 (2009).","journal-title":"J. Immunol."},{"key":"BFnrneurol2013118_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ana.21916","volume":"66","author":"F Brilot","year":"2009","unstructured":"Brilot, F. et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann. Neurol. 66, 833\u2013842 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2013118_CR27","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181e04096","volume":"74","author":"RC Selter","year":"2010","unstructured":"Selter, R. C. et al. Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases. Neurology 74, 1711\u20131715 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol2013118_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","volume":"138","author":"F Di Pauli","year":"2011","unstructured":"Di Pauli, F. et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin. Immunol. 138, 247\u2013254 (2011).","journal-title":"Clin. Immunol."},{"key":"BFnrneurol2013118_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/1352458510389220","volume":"17","author":"PH Lalive","year":"2011","unstructured":"Lalive, P. H. et al. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult. Scler. 17, 297\u2013302 (2011).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2013118_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","volume":"77","author":"AK Probstel","year":"2011","unstructured":"Probstel, A. K. et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77, 580\u2013588 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol2013118_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S Mader","year":"2011","unstructured":"Mader, S. et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J. Neuroinflamm. 8, 184 (2011).","journal-title":"J. Neuroinflamm."},{"key":"BFnrneurol2013118_CR32","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/archneurol.2011.2956","volume":"69","author":"K Rost\u00e1sy","year":"2012","unstructured":"Rost\u00e1sy, K. et al. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch. Neurol. 69, 752\u2013756 (2012).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2013118_CR33","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley, J. et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79, 1273\u20131277 (2012).","journal-title":"Neurology"},{"key":"BFnrneurol2013118_CR34","doi-asserted-by":"publisher","unstructured":"Rost\u00e1sy, K. et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult. Scler. http:\/\/dx.doi.org\/10.1177\/1352458512470310 .","DOI":"10.1177\/1352458512470310"},{"key":"BFnrneurol2013118_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1750-3639.1998.tb00194.x","volume":"8","author":"MK Storch","year":"1998","unstructured":"Storch, M. K. et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8, 681\u2013694 (1998).","journal-title":"Brain Pathol."},{"key":"BFnrneurol2013118_CR36","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/brain\/awh260","volume":"127","author":"H Sakuma","year":"2004","unstructured":"Sakuma, H. et al. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats. Brain 127, 2201\u20132213 (2004).","journal-title":"Brain"},{"key":"BFnrneurol2013118_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/brain\/awp321","volume":"133","author":"NP Young","year":"2010","unstructured":"Young, N. P. et al. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 133, 333\u2013348 (2010).","journal-title":"Brain"},{"key":"BFnrneurol2013118_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2353\/ajpath.2007.060893","volume":"170","author":"R Burrer","year":"2007","unstructured":"Burrer, R. et al. Exacerbated pathology of viral encephalitis in mice with central nervous system-specific autoantibodies. Am. J. Pathol. 170, 557\u2013566 (2007).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol2013118_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett, J. L. et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol. 66, 617\u2013629 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2013118_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.21837","volume":"66","author":"M Bradl","year":"2009","unstructured":"Bradl, M. et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 66, 630\u2013643 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2013118_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun, S. et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133, 349\u2013361 (2010).","journal-title":"Brain"},{"key":"BFnrneurol2013118_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-2007-1019130","volume":"28","author":"NP Young","year":"2008","unstructured":"Young, N. P., Weinshenker, B. G. & Lucchinetti, C. F. Acute disseminated encephalomyelitis: current understanding and controversies. Semin. Neurol. 28, 84\u201394 (2008).","journal-title":"Semin. Neurol."},{"issue":"Suppl. 2","key":"BFnrneurol2013118_CR43","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1212\/01.wnl.0000259422.44235.a8","volume":"68","author":"LB Krupp","year":"2007","unstructured":"Krupp, L. B., Banwell, B., Tenembaum, S. & International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 68 (Suppl. 2), S7\u2013S12 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol2013118_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/1352458512466317","volume":"19","author":"P Huppke","year":"2013","unstructured":"Huppke, P. et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult. Scler. 19, 941\u2013946 (2013).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2013118_CR45","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa067597","volume":"356","author":"C Renoux","year":"2007","unstructured":"Renoux, C. et al. Natural history of multiple sclerosis with childhood onset. N. Engl. J. Med. 356, 2603\u20132613 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2013118_CR46","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon, V. A. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106\u20132112 (2004).","journal-title":"Lancet"},{"key":"BFnrneurol2013118_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. & Hinson, S. R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473\u2013477 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrneurol2013118_CR48","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F. & Weinshenker, B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66, 1485\u20131489 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol2013118_CR49","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"PJ Waters","year":"2012","unstructured":"Waters, P. J. et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78, 665\u2013671 (2012).","journal-title":"Neurology"},{"key":"BFnrneurol2013118_CR50","doi-asserted-by":"publisher","unstructured":"Marignier, R. et al. Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology http:\/\/dx.doi.org\/10.1212\/WNL.0b013e318296e917 .","DOI":"10.1212\/WNL.0b013e318296e917"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2013.118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2013.118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2013.118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T15:48:22Z","timestamp":1688312902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2013.118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,25]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFnrneurol2013118"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2013.118","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,25]]}}}